Analyst Ratings for Medivation Inc (MDVN)

Updated: 2016-09-27

A number of analysts gave price targets for MDVN. The highest price target was 82, implying potential capital gains of 0.69 percent. The minimum price target given was 64, implying potential capital losses of -21.41 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -1.32 percent. That number becomes 1.37 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 8.29 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 1 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 1 analysts decreased their estimates.

MDVN has traded between a high of 81.48 and a low of 26.41 over the past year. The current market price is above the trailing year's low by 208.37 percent, and below the high by 0.05 percent. MDVN has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDVN value stock report compares MDVN to some of its peers using value stock charts. The market cap of MDVN is $13.57 billion. MDVN's next earnings release will be on 2016-11-03, which is -1051 days away.